-
1دورية أكاديمية
المؤلفون: Mato, AR, Roeker, LE, Lamanna, N, Allan, JN, Leslie, L, Pagel, JM, Patel, K, Osterborg, A, Wojenski, D, Kamdar, M, Huntington, SF, Davids, MS, Brown, JR, Antic, D, Jacobs, R, Ahn, IE, Pu, J, Isaac, KM, Barr, PM, Ujjani, CS, Geyer, MB, Berman, E, Zelenetz, AD, Malakhov, N, Furman, RR, Koropsak, M, Bailey, N, Hanson, L, Perini, GF, Ma, S, Ryan, CE, Wiestner, A, Portell, CA, Shadman, M, Chong, EA, Brander, DM, Sundaram, S, Seddon, AN, Seymour, E, Patel, M, Martinez-Calle, N, Munir, T, Walewska, R, Broom, A, Walter, H, El-Sharkawi, D, Parry, H, Wilson, MR, Patten, PEM, Hernandez-Rivas, JA, Miras, F, Escalada, NF, Ghione, P, Nabhan, C, Lebowitz, S, Bhavsar, E, Lopez-Jimenez, J, Naya, D, Garcia-Marco, JA, Skanland, SS, Cordoba, R, Eyre, TA
المصدر: Blood. 136(10):1134-1143
مصطلحات موضوعية: Medicin och hälsovetenskap
-
2دورية أكاديمية
المؤلفون: Shadman, M, Manzoor, BS, Sail, K, Tuncer, HH, Allan, JN, Ujjani, C, Emechebe, N, Kamalakar, R, Coombs, CC, Leslie, L, Barr, PM, Brown, JR, Eyre, TA, Rampotas, A, Schuh, A, Lamanna, N, Skarbnik, A, Roeker, LE, Bannerji, R, Eichhorst, B, Fleury, I, Davids, MS, Alhasani, H, Jiang, D, Hill, BT, Schuster, SJ, Brander, DM, Pivneva, I, Burne, R, Guerin, A, Mato, AR
المصدر: Clinical Lymphoma, Myeloma & Leukemia (2023) (In press).
مصطلحات موضوعية: Adverse events, Chemoimmunotherapy, Chemotherapy, Disease progression, Targeted agents
وصف الملف: text
العلاقة: https://discovery.ucl.ac.uk/id/eprint/10171712/1/Treatment%20Discontinuation%20CLL.pdfTest; https://discovery.ucl.ac.uk/id/eprint/10171712Test/
-
3دورية أكاديمية
المؤلفون: Zinzani, PL, Santoro, A, Gritti, G, Brice, P, Barr, PM, Kuruvilla, J, Cunningham, D, Kline, J, Johnson, NA, Mehta-Shah, N, Lisano, J, Wen, R, Akyol, A, Moskowitz, AJ
المساهمون: Cunningham, David
مصطلحات موضوعية: Adult, Humans, Brentuximab Vedotin, Nivolumab, Follow-Up Studies, Hodgkin Disease, Neoplasm Recurrence, Local, Lymphoma, B-Cell
جغرافية الموضوع: United States
وصف الملف: Print-Electronic; 5280; application/pdf
العلاقة: 496496; Blood Advances, 2023, 7 (18), pp. 5272 - 5280; https://repository.icr.ac.uk/handle/internal/5965Test
الإتاحة: https://doi.org/10.1182/bloodadvances.2023010254Test
https://repository.icr.ac.uk/handle/internal/5965Test -
4دورية أكاديمية
المؤلفون: Roeker, LE, Eyre, TA, Thompson, MC, Lamanna, N, Coltoff, AR, Davids, MS, Baker, PO, Leslie, L, Rogers, KA, Allan, JN, Cordoba, R, Lopez-Garcia, A, Antic, D, Pagel, JM, Martinez-Calle, N, Garcia-Moarco, JA, Hernandez-Rivas, JA, Miras, F, Coombs, CC, Osterborg, A, Hansson, L, Seddon, AN, Jimenez, JL, Wilson, MR, El-Sharkawi, D, Wojenski, D, Ma, S, Munir, T, Valenciano, S, Seymour, E, Barr, PM, Pu, JF, Patten, PEM, Perini, GF, Huntington, SF, Parry, H, Sundaram, S, Skarbnik, A, Kamdar, M, Jacobs, R, Walter, H, Walewska, R, Broom, A, Lebowitz, S, Isaac, KM, Portell, CA, Ahn, IE, Ujjani, CS, Shadman, M, Skanland, S, Chong, EA, Mato, AR
المصدر: Blood. 138(18):1768
مصطلحات موضوعية: Medicin och hälsovetenskap
-
5دورية أكاديمية
المؤلفون: Brown, JR, Hillmen, P, O’Brien, S, Barrientos, JC, Reddy, NM, Coutre, SE, Tam, CS, Mulligan, SP, Jaeger, U, Barr, PM, Furman, RR, Kipps, TJ, Cymbalista, F, Thornton, P, Caligaris-Cappio, F, Delgado, J, Montillo, M, DeVos, S, Moreno, C, Pagel, JM, Munir, T, Burger, JA, Chung, D, Lin, J, Gau, L, Chang, B, Cole, G, Hsu, E, James, DF, Byrd, JC
المصدر: Leukemia. 32(1)
مصطلحات موضوعية: Rare Diseases, Clinical Research, Lymphoma, Genetics, Cancer, Hematology, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Adenine, Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Disease-Free Survival, Female, Follow-Up Studies, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Male, Middle Aged, Mutation, Neoplasm Recurrence, Local, Piperidines, Prognosis, Pyrazoles, Pyrimidines, Tumor Suppressor Protein p53, Clinical Sciences, Oncology and Carcinogenesis, Immunology
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/9q42p90fTest
-
6دورية أكاديمية
المؤلفون: Tam, CS, Allan, JN, Siddiqi, T, Kipps, TJ, Jacobs, R, Opat, S, Barr, PM, Tedeschi, A, Trentin, L, Bannerji, R, Jackson, S, Kuss, BJ, Moreno, C, Szafer-Glusman, E, Russell, K, Zhou, C, Ninomoto, J, Dean, JP, Wierda, WG, Ghia, P
العلاقة: pii: S0006-4971(22)00246-4; Tam, C. S., Allan, J. N., Siddiqi, T., Kipps, T. J., Jacobs, R., Opat, S., Barr, P. M., Tedeschi, A., Trentin, L., Bannerji, R., Jackson, S., Kuss, B. J., Moreno, C., Szafer-Glusman, E., Russell, K., Zhou, C., Ninomoto, J., Dean, J. P., Wierda, W. G. & Ghia, P. (2022). Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort. BLOOD, 139 (22), pp.3278-3289. https://doi.org/10.1182/blood.2021014488Test.; http://hdl.handle.net/11343/301630Test
-
7دورية أكاديمية
المؤلفون: Barr, PM, Tedeschi, A, Wierda, WG, Allan, JN, Ghia, P, Vallisa, D, Jacobs, R, O'Brien, S, Grigg, AP, Walker, P, Zhou, C, Ninomoto, J, Krigsfeld, G, Tam, CS
العلاقة: pii: 707537; Barr, P. M., Tedeschi, A., Wierda, W. G., Allan, J. N., Ghia, P., Vallisa, D., Jacobs, R., O'Brien, S., Grigg, A. P., Walker, P., Zhou, C., Ninomoto, J., Krigsfeld, G. & Tam, C. S. (2022). Effective Tumor Debulking with Ibrutinib Before Initiation of Venetoclax: Results from the CAPTIVATE Minimal Residual Disease and Fixed-Duration Cohorts. CLINICAL CANCER RESEARCH, 28 (20), pp.4385-4391. https://doi.org/10.1158/1078-0432.CCR-22-0504Test.; http://hdl.handle.net/11343/320162Test
-
8دورية أكاديمية
المؤلفون: Thompson, MC, Harrup, RA, Coombs, CC, Roeker, LE, Pu, JJ, Choi, MY, Barr, PM, Allan, JN, Simkovic, M, Leslie, L, Rhodes, J, Chong, EA, Kamdar, M, Skarbnik, A, Lansigan, F, McCall, B, Saja, K, Dyer, MJS, Walter, HS, Lefebure, M, Thadani-Mulero, M, Boyer, M, Biondo, J, Sail, K, Manzoor, BS, Furman, R, Bantilan, KS, Goy, A, Feldman, T, Labella, D, Schuster, SJ, Park, J, Palomba, L, Zelenetz, A, Eyre, TA, Kater, AP, Seymour, JF, Mato, AR
العلاقة: pii: 485664; Thompson, M. C., Harrup, R. A., Coombs, C. C., Roeker, L. E., Pu, J. J., Choi, M. Y., Barr, P. M., Allan, J. N., Simkovic, M., Leslie, L., Rhodes, J., Chong, E. A., Kamdar, M., Skarbnik, A., Lansigan, F., McCall, B., Saja, K., Dyer, M. J. S., Walter, H. S. ,. Mato, A. R. (2022). Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen. BLOOD ADVANCES, 6 (15), pp.4553-4557. https://doi.org/10.1182/bloodadvances.2022007812Test.; http://hdl.handle.net/11343/318180Test
-
9دورية أكاديمية
المؤلفون: Cuneo, A, Mato, AR, Rigolin, GM, Piciocchi, A, Gentile, M, Laurenti, L, Allan, JN, Pagel, JM, Brander, DM, Hill, BT, Winter, A, Lamanna, N, Tam, CS, Jacobs, R, Lansigan, F, Barr, PM, Shadman, M, Skarbnik, AP, Pu, JJ, Sehgal, AR, Schuster, SJ, Shah, NN, Ujjani, CS, Roeker, L, Orlandi, EM, Billio, A, Trentin, L, Spacek, M, Marchetti, M, Tedeschi, A, Ilariucci, F, Gaidano, G, Doubek, M, Farina, L, Molica, S, Di Raimondo, F, Coscia, M, Mauro, FR, de la Serna, J, Medina Perez, A, Ferrarini, I, Cimino, G, Cavallari, M, Cucci, R, Vignetti, M, Foa, R, Ghia, P
العلاقة: Cuneo, A., Mato, A. R., Rigolin, G. M., Piciocchi, A., Gentile, M., Laurenti, L., Allan, J. N., Pagel, J. M., Brander, D. M., Hill, B. T., Winter, A., Lamanna, N., Tam, C. S., Jacobs, R., Lansigan, F., Barr, P. M., Shadman, M., Skarbnik, A. P., Pu, J. J. ,. Ghia, P. (2020). Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study. CANCER MEDICINE, 9 (22), pp.8468-8479. https://doi.org/10.1002/cam4.3470Test.; http://hdl.handle.net/11343/271945Test
-
10دورية أكاديمية
المؤلفون: Munir, T, Brown, JR, O'Brien, S, Barrientos, JC, Barr, PM, Reddy, NM, Coutre, S, Tam, CS, Mulligan, SP, Jaeger, U, Kipps, TJ, Moreno, C, Montillo, M, Burger, JA, Byrd, JC, Hillmen, P, Dai, S, Szoke, A, Dean, JP, Woyach, JA
العلاقة: Munir, T., Brown, J. R., O'Brien, S., Barrientos, J. C., Barr, P. M., Reddy, N. M., Coutre, S., Tam, C. S., Mulligan, S. P., Jaeger, U., Kipps, T. J., Moreno, C., Montillo, M., Burger, J. A., Byrd, J. C., Hillmen, P., Dai, S., Szoke, A., Dean, J. P. & Woyach, J. A. (2019). Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma. AMERICAN JOURNAL OF HEMATOLOGY, 94 (12), pp.1353-1363. https://doi.org/10.1002/ajh.25638Test.; http://hdl.handle.net/11343/245222Test
النص الكامل